Verisign Reports 15 Percent Year-Over-Year Revenue Growth in First Quarter 2013
First Quarter GAAP Financial Results
First Quarter Non-GAAP Financial Results
"The first quarter demonstrates our continued focus and discipline in the execution of our strategic framework," commented
"We are pleased with the successful completion of our
Financial Highlights
- On
April 16, 2013 ,Verisign issued$750 million of 4.625% Senior Notes dueMay 2023 .Verisign used a portion of the proceeds from the offering to repay the$100 million in outstanding indebtedness under its existing revolving credit facility and intends to use the remaining amount for general corporate purposes, including, but not limited to, the repurchase of shares under its share repurchase program. Verisign ended the first quarter with Cash, Cash Equivalents,Marketable Securities and Restricted Cash of$1.57 billion , an increase of$9 million from year-end 2012.- Cash flow from operations was
$151 million for the first quarter compared with$110 million for the same quarter in 2012. - Deferred revenues on
March 31, 2013 , totaled$847 million , an increase of$34 million from year-end 2012. - Capital expenditures were
$17 million in the first quarter of 2013. - During the first quarter,
Verisign repurchased approximately 3.0 million shares of its common stock for a cost of approximately$132 million . AtMarch 31, 2013 , approximately$844 million remained available and authorized under the current share repurchase program. - For purposes of calculating diluted EPS, the first quarter diluted share count included 7.9 million shares related to the subordinated convertible debentures, compared with 2.5 million shares in the same quarter in 2012. These represent diluted shares and not shares that have been issued.
- Due to the stock price exceeding the subordinated convertible debentures trigger price during the first quarter of 2013, holders have the option to convert the debentures into common stock during the second quarter of 2013. Consequently, the debt component of the subordinated convertible debentures, the related embedded derivative, and deferred tax liability were reclassified from long-term liabilities to current liabilities, while the associated unamortized debt issuance costs were reclassified from long-term assets to current assets, as of
March 31, 2013 .
Business Highlights
- Verisign Registry Services added 1.99 million net new names and ended the first quarter with 123.1 million active domain names in the zone for .com and .net, representing a 5.5 percent increase year over year.
- In the first quarter,
Verisign processed 8.8 million new domain name registrations as compared to 8.9 million for the same quarter a year prior.
Non-GAAP Items
Non-GAAP financial results exclude the following items that are included under GAAP: discontinued operations, stock-based compensation, amortization of other intangible assets, impairments of goodwill and other intangible assets, restructuring charges, contingent interest payments to holders of the subordinated convertible debentures, unrealized gain/loss on contingent interest derivative on subordinated convertible debentures, and non-cash interest expense. Non-GAAP financial information is also adjusted for a 28 percent tax rate starting from the third quarter of 2012, and 30 percent for the other periods presented herein, both of which differ from the GAAP tax rate. A table reconciling the GAAP to non-GAAP operating income and net income is appended to this release.
Today's Conference Call
About
As the global leader in domain names,
VRSNF
Statements in this announcement other than historical data and information constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. These statements involve risks and uncertainties that could cause our actual results to differ materially from those stated or implied by such forward-looking statements. The potential risks and uncertainties include, among others, the uncertainty of whether the
©2013
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||||
(In thousands, except par value) | ||||||||||
(Unaudited) | ||||||||||
2013 |
2012 |
|||||||||
ASSETS | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | $ | 78,620 | $ | 130,736 | ||||||
Marketable securities | 1,483,827 | 1,425,700 | ||||||||
Accounts receivable, net | 13,617 | 11,477 | ||||||||
Deferred tax assets | 286 | 44,756 | ||||||||
Prepaid expenses and other current assets | 38,849 | 30,795 | ||||||||
Total current assets | 1,615,199 | 1,643,464 | ||||||||
Property and equipment, net | 333,183 | 333,861 | ||||||||
Goodwill | 52,527 | 52,527 | ||||||||
Long-term deferred tax assets | 52,793 | 7,299 | ||||||||
Other long-term assets | 17,411 | 25,325 | ||||||||
Total long-term assets | 455,914 | 419,012 | ||||||||
Total assets | $ | 2,071,113 | $ | 2,062,476 | ||||||
LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||||
Current liabilities: | ||||||||||
Accounts payable and accrued liabilities | $ | 119,986 | $ | 130,391 | ||||||
Subordinated convertible debentures, including contingent interest derivative | 606,142 | - | ||||||||
Deferred revenues | 591,356 | 564,627 | ||||||||
Deferred tax liabilities | 388,923 | - | ||||||||
Total current liabilities | 1,706,407 | 695,018 | ||||||||
Long-term deferred revenues | 255,438 | 247,955 | ||||||||
Subordinated convertible debentures, including contingent interest derivative | - | 597,614 | ||||||||
Long-term debt | 100,000 | 100,000 | ||||||||
Long-term deferred tax liabilities | 3,657 | 386,914 | ||||||||
Other long-term tax liabilities | 44,747 | 44,298 | ||||||||
Total long-term liabilities | 403,842 | 1,376,781 | ||||||||
Total liabilities | 2,110,249 | 2,071,799 | ||||||||
Commitments and contingencies | ||||||||||
Stockholders' deficit: | ||||||||||
Preferred stock-par value |
- | - | ||||||||
Common stock-par value |
320 | 319 | ||||||||
Additional paid-in capital | 19,777,251 | 19,891,291 | ||||||||
Accumulated deficit | (19,816,032 | ) | (19,900,545 | ) | ||||||
Accumulated other comprehensive loss | (675 | ) | (388 | ) | ||||||
Total stockholders' deficit | (39,136 | ) | (9,323 | ) | ||||||
Total liabilities and stockholders' deficit | $ | 2,071,113 | $ | 2,062,476 | ||||||
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME | ||||||||||
(In thousands, except per share data) | ||||||||||
(Unaudited) | ||||||||||
Three Months Ended |
||||||||||
2013 | 2012 | |||||||||
Revenues | $ | 236,447 | $ | 205,726 | ||||||
Costs and expenses: | ||||||||||
Cost of revenues | 47,254 | 41,256 | ||||||||
Sales and marketing | 18,104 | 27,815 | ||||||||
Research and development | 18,176 | 14,765 | ||||||||
General and administrative | 19,649 | 23,508 | ||||||||
Restructuring charges | - | (548 | ) | |||||||
Total costs and expenses | 103,183 | 106,796 | ||||||||
Operating income | 133,264 | 98,930 | ||||||||
Interest expense | (12,596 | ) | (12,340 | ) | ||||||
Non-operating (loss) income, net | (5,777 | ) | 807 | |||||||
Income from continuing operations before income taxes | 114,891 | 87,397 | ||||||||
Income tax expense | (30,378 | ) | (21,292 | ) | ||||||
Income from continuing operations, net of tax | 84,513 | 66,105 | ||||||||
Income from discontinued operations, net of tax | - | 1,904 | ||||||||
Net income | 84,513 | 68,009 | ||||||||
Unrealized loss on investments, net of tax | (267 | ) | (5 | ) | ||||||
Realized gain on investments, net of tax, included in net income | (20 | ) | (5 | ) | ||||||
Other comprehensive loss | (287 | ) | (10 | ) | ||||||
Comprehensive income | $ | 84,226 | $ | 67,999 | ||||||
Basic income per share: | ||||||||||
Continuing operations | $ | 0.55 | $ | 0.41 | ||||||
Discontinued operations | - | 0.02 | ||||||||
Net income | $ | 0.55 | $ | 0.43 | ||||||
Diluted income per share: | ||||||||||
Continuing operations | $ | 0.52 | $ | 0.41 | ||||||
Discontinued operations | - | 0.01 | ||||||||
Net income | $ | 0.52 | $ | 0.42 | ||||||
Shares used to compute net income per share | ||||||||||
Basic | 152,543 | 159,344 | ||||||||
Diluted | 161,346 | 162,881 | ||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||||||
(In thousands) | ||||||||||||
(Unaudited) | ||||||||||||
Three Months Ended |
||||||||||||
2013 | 2012 | |||||||||||
Cash flows from operating activities: | ||||||||||||
Net income | $ | 84,513 | $ | 68,009 | ||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
Depreciation of property and equipment and amortization of other intangible assets | 15,118 | 12,741 | ||||||||||
Stock-based compensation | 7,594 | 8,130 | ||||||||||
Excess tax benefit associated with stock-based compensation | (11,808 | ) | (3,567 | ) | ||||||||
Deferred income taxes | 4,787 | 10,560 | ||||||||||
Other, net | 10,742 | 1,006 | ||||||||||
Changes in operating assets and liabilities | ||||||||||||
Accounts receivable | (2,280 | ) | 1,392 | |||||||||
Prepaid expenses and other assets | 3,210 | 9,822 | ||||||||||
Accounts payable and accrued liabilities | 4,549 | (52,534 | ) | |||||||||
Deferred revenues | 34,212 | 54,719 | ||||||||||
Net cash provided by operating activities | 150,637 | 110,278 | ||||||||||
Cash flows from investing activities: | ||||||||||||
Proceeds from maturities and sales of marketable securities | 706,244 | 5,060 | ||||||||||
Purchases of marketable securities | (764,268 | ) | (5,082 | ) | ||||||||
Purchases of property and equipment | (17,115 | ) | (12,917 | ) | ||||||||
Other investing activities | (3,426 | ) | - | |||||||||
Net cash used in investing activities | (78,565 | ) | (12,939 | ) | ||||||||
Cash flows from financing activities: | ||||||||||||
Proceeds from issuance of common stock from option exercises and employee stock purchase plans | 8,733 | 11,390 | ||||||||||
Repurchases of common stock | (142,892 | ) | (75,149 | ) | ||||||||
Excess tax benefit associated with stock-based compensation | 11,808 | 3,567 | ||||||||||
Other financing activities | - | 189 | ||||||||||
Net cash used in financing activities | (122,351 | ) | (60,003 | ) | ||||||||
Effect of exchange rate changes on cash and cash equivalents | (1,837 | ) | 2,355 | |||||||||
Net (decrease) increase in cash and cash equivalents | (52,116 | ) | 39,691 | |||||||||
Cash and cash equivalents at beginning of period | 130,736 | 1,313,349 | ||||||||||
Cash and cash equivalents at end of period | $ | 78,620 | $ | 1,353,040 | ||||||||
Supplemental cash flow disclosures: | ||||||||||||
Cash paid for interest, net of capitalized interest | $ | 20,393 | $ | 20,036 | ||||||||
Cash paid for income taxes, net of refunds received | $ | 729 | $ | 13,186 | ||||||||
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES | ||||||||||||||||||
(In thousands, except per share data) | ||||||||||||||||||
(Unaudited) | ||||||||||||||||||
Three Months Ended | Three Months Ended | |||||||||||||||||
Operating Income | Net Income | Operating Income | Net Income | |||||||||||||||
GAAP as reported | $ | 133,264 | $ | 84,513 | $ | 98,930 | $ | 68,009 | ||||||||||
Discontinued operations | (1,904 | ) | ||||||||||||||||
Adjustments: | ||||||||||||||||||
Stock-based compensation | 7,594 | 7,594 | 8,130 | 8,130 | ||||||||||||||
Amortization of other intangible assets | - | - | 323 | 323 | ||||||||||||||
Restructuring charges | - | - | (548 | ) | (548 | ) | ||||||||||||
Unrealized loss on contingent interest derivative on the subordinated convertible debentures | 6,433 | 813 | ||||||||||||||||
Non-cash interest expense | 1,914 | 1,620 | ||||||||||||||||
Tax adjustment | (6,255 | ) | (8,028 | ) | ||||||||||||||
Non-GAAP | $ | 140,858 | $ | 94,199 | $ | 106,835 | $ | 68,415 | ||||||||||
Revenues | $ | 236,447 | $ | 205,726 | ||||||||||||||
Non-GAAP operating margin | 59.6 | % | 51.9 | % | ||||||||||||||
Diluted shares | 161,346 | 162,881 | ||||||||||||||||
Per diluted share, non-GAAP | $ | 0.58 | $ | 0.42 | ||||||||||||||
Management believes that this non-GAAP financial data supplements the GAAP financial data by providing investors with additional information that allows them to have a clearer picture of
SUPPLEMENTAL FINANCIAL INFORMATION | |
The following table presents the classification of stock-based compensation: | |
Three Months Ended |
||||||
2013 | 2012 | |||||
Cost of revenues | $ | 1,540 | $ | 1,537 | ||
Sales and marketing | 1,487 | 1,516 | ||||
Research and development | 1,895 | 1,242 | ||||
General and administrative | 2,672 | 3,835 | ||||
Total stock-based compensation expense | $ | 7,594 | $ | 8,130 | ||
SUPPLEMENTARY FINANCIAL INFORMATION |
(Unaudited) |
Following the offering of the 4.625% Senior Notes due 2023 (the "Notes"),
The following table reconciles GAAP net income to Adjusted EBITDA for the periods shown below (in thousands):
Three Months Ended |
|||||||||
2013 | 2012 | ||||||||
Net Income | $ | 84,513 | $ | 68,009 | |||||
Interest expense | 12,596 | 12,340 | |||||||
Income tax expense | 30,378 | 21,474 | |||||||
Depreciation and amortization | 15,118 | 12,741 | |||||||
Stock-based compensation | 7,594 | 8,130 | |||||||
Unrealized loss on contingent interest derivative on the subordinated convertible debentures | 6,433 | 813 | |||||||
Unrealized gain on hedging agreements | (894 | ) | (274 | ) | |||||
Adjusted EBITDA | $ | 155,738 | $ | 123,233 | |||||
Four Quarters Ended | |||||
Net Income | $ | 336,535 | |||
Interest expense | 50,452 | ||||
Income tax expense | 112,710 | ||||
Depreciation and amortization | 57,195 | ||||
Stock-based compensation | 32,826 | ||||
Unrealized loss on contingent interest derivative on the subordinated convertible debentures | 5,198 | ||||
Unrealized gain on hedging agreements | (321 | ) | |||
Adjusted EBITDA | $ | 594,595 |
- Adjusted EBITDA does not reflect
Verisign's cash expenditures, or future requirements, for capital expenditures or contractual commitments; - Adjusted EBITDA does not reflect changes in, or cash requirements for,
Verisign's working capital needs; - Adjusted EBITDA does not reflect the significant interest expense, or the cash requirements necessary to service interest or principal payments, on
Verisign's debts; - although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements;
- non-cash compensation is and will remain a key element of
Verisign's overall long-term incentive compensation package, althoughVerisign excludes it as an expense when evaluating its ongoing operating performance for a particular period; and - other companies in our industry may calculate Adjusted EBITDA differently than
Verisign does, limiting its usefulness as a comparative measure.
Because of these limitations, Adjusted EBITDA should not be considered in isolation or as a substitute for performance measures calculated in accordance with GAAP.
Source:
News Provided by Acquire Media